Landscape on CT screening for lung cancer in Asia

Natthaya Triphuridet,1,2 Claudia Henschke2 1Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand; 2Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence: Claudia HenschkeIcah...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Triphuridet N, Henschke C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Lung cancer CT screening LDCT Asia guidelines Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/f08e2e0748064fa1bdfd2a2544a06c02
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f08e2e0748064fa1bdfd2a2544a06c02
record_format	dspace
spelling	oai:doaj.org-article:f08e2e0748064fa1bdfd2a2544a06c022021-12-02T04:40:54ZLandscape on CT screening for lung cancer in Asia1179-2728https://doaj.org/article/f08e2e0748064fa1bdfd2a2544a06c022019-09-01T00:00:00Zhttps://www.dovepress.com/landscape-on-ct-screening-for-lung-cancer-in-asia-peer-reviewed-article-LCTThttps://doaj.org/toc/1179-2728Natthaya Triphuridet,1,2 Claudia Henschke2 1Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand; 2Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence: Claudia HenschkeIcahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY 10029, USATel +1 212 241 2821Fax +1 212 241 9655Email claudia.henschke@mountsinai.orgAbstract: Lung cancer remains the leading cause of cancer incidence and mortality worldwide. Approximately 60% of the world’s new cases of lung cancer and deaths from it are expected in Asia in 2018. Currently, lung cancer screening using low-dose computed tomography (LDCT) is recommended for heavy smokers in North America, Europe and some countries in Asia. Tobacco smoking being the major risk factor for lung cancer, but in Asia, lung cancer in never-smokers (LCINS) is also a concern. This paper reviews on lung cancer incidence, mortality, etiology, smoking in Asia, and systematic reviews on LDCT lung cancer screening studies, including ongoing projects and recommendation on lung cancer screening in Asia. Some of the earliest studies of LDCT lung cancer screening worldwide were in Asia. Many countries in Asia have developed LDCT screening studies in various high-risk participants. Currently, there are several ongoing large-scale lung cancer screening trials to evaluate the efficacy of LDCT screening for never-smokers and light smokers, as well as heavy smokers, and to evaluate the feasibility of population-based LDCT lung cancer screening.Keywords: lung cancer, CT screening, LDCT, Asia, guidelinesTriphuridet NHenschke CDove Medical PressarticleLung cancerCT screeningLDCTAsiaguidelinesNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENLung Cancer: Targets and Therapy, Vol Volume 10, Pp 107-124 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Lung cancer CT screening LDCT Asia guidelines Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Lung cancer CT screening LDCT Asia guidelines Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Triphuridet N Henschke C Landscape on CT screening for lung cancer in Asia
description	Natthaya Triphuridet,1,2 Claudia Henschke2 1Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand; 2Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence: Claudia HenschkeIcahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1234, New York, NY 10029, USATel +1 212 241 2821Fax +1 212 241 9655Email claudia.henschke@mountsinai.orgAbstract: Lung cancer remains the leading cause of cancer incidence and mortality worldwide. Approximately 60% of the world’s new cases of lung cancer and deaths from it are expected in Asia in 2018. Currently, lung cancer screening using low-dose computed tomography (LDCT) is recommended for heavy smokers in North America, Europe and some countries in Asia. Tobacco smoking being the major risk factor for lung cancer, but in Asia, lung cancer in never-smokers (LCINS) is also a concern. This paper reviews on lung cancer incidence, mortality, etiology, smoking in Asia, and systematic reviews on LDCT lung cancer screening studies, including ongoing projects and recommendation on lung cancer screening in Asia. Some of the earliest studies of LDCT lung cancer screening worldwide were in Asia. Many countries in Asia have developed LDCT screening studies in various high-risk participants. Currently, there are several ongoing large-scale lung cancer screening trials to evaluate the efficacy of LDCT screening for never-smokers and light smokers, as well as heavy smokers, and to evaluate the feasibility of population-based LDCT lung cancer screening.Keywords: lung cancer, CT screening, LDCT, Asia, guidelines
format	article
author	Triphuridet N Henschke C
author_facet	Triphuridet N Henschke C
author_sort	Triphuridet N
title	Landscape on CT screening for lung cancer in Asia
title_short	Landscape on CT screening for lung cancer in Asia
title_full	Landscape on CT screening for lung cancer in Asia
title_fullStr	Landscape on CT screening for lung cancer in Asia
title_full_unstemmed	Landscape on CT screening for lung cancer in Asia
title_sort	landscape on ct screening for lung cancer in asia
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/f08e2e0748064fa1bdfd2a2544a06c02
work_keys_str_mv	AT triphuridetn landscapeonctscreeningforlungcancerinasia AT henschkec landscapeonctscreeningforlungcancerinasia
_version_	1718401163520376832

Landscape on CT screening for lung cancer in Asia

Ejemplares similares